On December 2, 2024, Bank J. Safra Sarasin AG announced the acquisition of 100% of the shares of MIV Asset Management AG ("MIV").

MIV is characterized through its investments in medical technology and its flagship fund, the MIV Global Medtech Fund. MIV is known for its innovative approach and in-depth knowledge of the sector. MIV's offering is an addition to Bank J. Safra Sarasin's range of thematic equity strategies, which are available to both private and institutional investors.

MIV's investment strategy and organizational structure will remain unchanged to ensure solid performance and seamless client service.

The Homburger team advising the selling shareholders was led by Daniel Hasler and Daniel Daeniker and included Stefan Blunschi, Caspar Wehrle, Bianca Nedwed and Felix Beltle (all Corporate / M&A), Marc Bircher (Litigation), Jürg Frick and Philipp Klein (both Financial Market Regulation), Stefan Oesterhelt, Peter Müller and Philipp Stiegeler (all Tax) as well as Jeremy Reichlin (Employment and Executive Compensation).